Fishy Whales
Security

PHAT · Phathom Pharmaceuticals Inc

40 institutional holder(s) · 0 congressional trade(s)
← Funds
Phathom Pharmaceuticals Inc appears in the public filings tracked here. It is held by 12 of 26 tracked funds in the latest quarter.

Institutional holders

13F
FundValueShares
Vanguard Group $125.1M5,945,140
Vanguard Group $46.7M2,812,646
BlackRock $45.4M5,251,872
Carlyle Group $37.9M3,496,808
Millennium Management $36.6M3,375,834
BlackRock $34.6M4,005,567
State Street $30.1M3,481,349
BlackRock $28.1M2,593,818
Geode Capital Management $23.7M2,738,762
Citadel Advisors $19.1M2,211,338
State Street $17.2M1,586,323
Vanguard Group $16.5M785,901
BlackRock $15M1,384,837
Geode Capital Management $12.3M1,130,751
State Street $10.9M11,407,000
Millennium Management $9.9M1,145,837
Morgan Stanley $9.4M1,086,624
Fidelity $8M924,711
BlackRock $7.6M7,930,000
Bank of America $7.3M843,436
Two Sigma Investments $7.1M823,496
Bank of America $6.9M792,137
Two Sigma Investments $5.6M519,076
BlackRock $5.5M634,236
BlackRock $5.3M608,828
Citadel Advisors $5.2M480,800
Vanguard Group $5M299,548
Geode Capital Management $3.9M450,132
Fidelity $3.8M4,024,000
BlackRock $2.9M338,338
Bank of America $2.5M290,012
Morgan Stanley $2.5M284,892
Morgan Stanley $2.5M2,585,000
Renaissance Technologies $2.5M284,500
Renaissance Technologies $2.5M226,400
Bank of America $2.4M2,541,000
BlackRock $2.4M272,415
Citadel Advisors $2.2M250,062
Geode Capital Management $2M184,936
Citadel Advisors $2M184,901

Congressional trades

STOCK Act
MemberTypeDate
No congressional trade for “PHAT”.